CERKL (NM_201548) Human Recombinant Protein
CAT#: TP323592
Recombinant protein of human ceramide kinase-like (CERKL), transcript variant 1
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293T |
Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC223592. Click on the TrueORF clone link to view cDNA and protein sequences.
|
Tag | C-Myc/DDK |
Predicted MW | 59.4 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_963842 |
Locus ID | 375298 |
UniProt ID | Q49MI3 |
Cytogenetics | 2q31.3 |
Refseq Size | 3123 |
Refseq ORF | 1596 |
Synonyms | RP26 |
Summary | This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts. [provided by RefSeq, May 2010] |
Protein Families | Druggable Genome |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC400410 | CERKL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC404454 | CERKL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC422210 | CERKL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC422211 | CERKL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC430873 | CERKL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC431449 | CERKL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY400410 | Transient overexpression lysate of ceramide kinase-like (CERKL), transcript variant 2 |
USD 605.00 |
|
LY404454 | Transient overexpression lysate of ceramide kinase-like (CERKL), transcript variant 1 |
USD 605.00 |
|
LY422210 | Transient overexpression lysate of ceramide kinase-like (CERKL), transcript variant 3 |
USD 605.00 |
|
LY422211 | Transient overexpression lysate of ceramide kinase-like (CERKL), transcript variant 4 |
USD 605.00 |
|
LY430873 | Transient overexpression lysate of ceramide kinase-like (CERKL), transcript variant 1 |
USD 396.00 |
|
LY431449 | Transient overexpression lysate of ceramide kinase-like (CERKL), transcript variant 7 |
USD 396.00 |
|
PH323592 | CERKL MS Standard C13 and N15-labeled recombinant protein (NP_963842) |
USD 2,055.00 |
{0} Product Review(s)
Be the first one to submit a review